Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells.

J Control Release

Department of Pharmaceutical Sciences, Center for Integrated Biotechnology, Washington State University, Pullman, WA 99164, USA.

Published: September 2009

A novel multi-domain biopolymer was designed and genetically engineered with the purpose to target and transfect cancer cells. The biopolymer contains at precise locations: 1) repeating units of arginine and histidine to condense pDNA and lyse endosome membranes, 2) a HER2 targeting affibody to target cancer cells, 3) a pH responsive fusogenic peptide to destabilize endosome membranes and enhance endosomolytic activity of histidine residues, and 4) a nuclear localization signal to enhance translocation of pDNA towards the cell nucleus. The results demonstrated that the biopolymer was able to condense pDNA into nanosize particles, protect pDNA from serum endonucleases, target HER2 positive cancer cells but not HER2 negative ones, efficiently disrupt endosomes, and effectively reach the cell nucleus of target cells to mediate gene expression. To reduce potential toxicity and enhance biodegradability, the biopolymer was designed to be susceptible to digestion by endogenous furin enzymes inside the cells. The results revealed no significant biopolymer related toxicity as determined by impact on cell viability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920211PMC
http://dx.doi.org/10.1016/j.jconrel.2009.04.017DOI Listing

Publication Analysis

Top Keywords

cancer cells
16
genetically engineered
8
biopolymer designed
8
condense pdna
8
endosome membranes
8
cell nucleus
8
cells
6
biopolymer
5
biosynthesis characterization
4
characterization novel
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!